13 July, 2017
Johnson & Johnson (Call) now has $355.34B valuation.
Many analysts are providing their Estimated Earnings analysis for Johnson & Johnson and for the current quarter 18 analysts have projected that the stock could give an Average Earnings estimate of $1.8/share. About 146 shares traded. It has underperformed by 4.16% the S&P500. Tillar reported 17,820 shares. The institutional investor held 74,038 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $8.53M, up from 66,175 at the end of the previous reported quarter. The Maryland-based Advisors Preferred Llc has invested 0.2% in the stock. It has underperformed by 35.98% the S&P500.
Among 12 analysts covering Republic Services (NYSE:RSG), 5 have Buy rating, 0 Sell and 7 Hold. Therefore 50% are positive. The stock presently has a consensus rating of "Buy" and an average price target of $131.45. BMO Capital Markets maintained the shares of JNJ in report on Monday, July 10 with "Buy" rating. On Friday, May 20 the stock rating was initiated by Standpoint Research with "Sell". The firm earned "Overweight" rating on Tuesday, December 1 by Barclays Capital. As per Thursday, January 26, the company rating was downgraded by Wells Fargo. On Monday, October 5 the stock rating was reinitiated by Piper Jaffray with "Neutral". The company was maintained on Wednesday, October 7 by RBC Capital Markets.
Since January 1, 0001, it had 1 buying transaction, and 0 sales for $28,542 activity. 22,000 shares were sold by Stoffels Paulus, worth $2.58M on Wednesday, February 15. As per Wednesday, April 20, the company rating was maintained by Argus Research. (NYSE:DG) for 3.62M shares. 9,500 shares were sold by Serianni Charles F, worth $583,627. Berson & Corrado Investment Advisors LLC boosted its position in shares of Johnson & Johnson by 0.7% in the first quarter. Regal Invest Advsrs Limited Liability Corporation reported 0.67% stake. Raymond James has 4,761 shares.
Investors sentiment increased to 1.14 in 2016 Q4. Its down 0.01, from 0.88 in 2016Q3. It increased, as 34 investors sold CIT shares while 99 reduced holdings. 59 funds opened positions while 179 raised stakes. Systematic Mngmt Limited Partnership reported 148,916 shares. 147,950 were accumulated by Beaumont Finance Ptnrs Ltd Llc. Moreover, Bank & Trust Of Hawaii has 0.82% invested in The Coca-Cola Co (NYSE:KO). Smith Moore & reported 1.01% stake. Country Trust Retail Bank stated it has 329,035 shares or 1.93% of all its holdings. The fund owned 49,378 shares of the company's stock after buying an additional 3,068 shares during the period. The Massachusetts-based Baupost Group Llc Ma has invested 7% in the stock. Spot Trading Lc holds 19,763 shares. Airain invested 0.1% of its portfolio in The Coca-Cola Co (NYSE:KO). Catawba Management Va invested 0.82% in Dollar General Corp. Yacktman Asset LP holds 16.65M shares. The target implies a 8.65% spike from where the shares are now trading. Segment Wealth Mngmt Llc holds 1.65% or 39,139 shares in its portfolio. Rutabaga Capital Management Llc Ma owns 283,206 shares or 0.67% of their United States portfolio.
Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, April 18th. JNJ's profit will be $4.78 billion for 18.43 P/E if the $1.78 EPS becomes a reality. The company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.06. This is an increase from Johnson & Johnson's previous quarterly dividend of $0.80. Its up 0.11, from 1.03 in 2016Q3. Gateway Investment Advisers LLC bolstered its holdings by buying 30,640 shares an increase of 2.1% from 03/31/2017 to 06/30/2017. Berson & Corrado Investment Advisors LLC raised its position in Johnson & Johnson by 0.7% in the first quarter. 62,190 are owned by Blue Chip Prtnrs Incorporated. Cullen Cap Mgmt Limited has 698,630 shares for 2.78% of their portfolio. Northeast Investment has 2.79% invested in Johnson & Johnson (NYSE:JNJ) for 252,087 shares. Parsec Management reported 1.62% in Johnson & Johnson (NYSE:JNJ). Ruffer Llp invested 0.12% of its portfolio in Johnson & Johnson (NYSE:JNJ). 23,874 were reported by Aureus Asset Management Limited Liability Company. Inc. holds 6.23% of its portfolio in Seneca Foods Corp for 76,150 shares. Texas-based Maverick Capital Ltd has invested 0.04% in Johnson & Johnson (NYSE:JNJ). Johnson & Johnson (JNJ) has made its way to a 12-month gain of 6.75%. Therefore 75% are positive. Johnson & Johnson had 46 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned "Buy" rating on Tuesday, September 22 by UBS. Royal Bank Of Canada reaffirmed a "buy" rating and set a $138.00 price target on shares of Johnson & Johnson in a research report on Wednesday.
More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Fiercebiotech.com which released: "Video Interviewâ€"Johnson & Johnson Innovation" on July 10, 2017, also Seekingalpha.com with their article: "Johnson & Johnson: Where's The Growth Coming From?" published on July 05, 2017, Barrons.com published: "Johnson & Johnson: Good, Not Great?" on July 05, 2017". The stock has "Hold" rating by Jefferies on Thursday, July 14.
Since February 1, 2017, it had 0 buys, and 5 sales for $14.98 million activity. 50,000 shares were sold by Duato Joaquin, worth $6.18 million. Pruden Gary J had sold 16,299 shares worth $1.99 million. 21,735 shares were sold by Ullmann Michael H, worth $2.45 million on Wednesday, February 1. The insider Kapusta Ronald A sold 14,543 shares worth $1.78M.
